Haixia Cao

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Ejection Fraction

Diffuse Large B Cell Lymphoma

Epstein Barr Virus

Patient Reported Outcomes

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Ying Sui, Ziyang Shen, Xiaoyou Li, Ya Lu, SiTong Feng, Rong Ma, Jianzhong Wu, Changwen Jing, Zhuo Wang, Ji-Feng Feng, Haixia Cao
Rupatadine-inhibited OTUD3 promotes DLBCL progression and immune evasion through deubiquitinating MYL12A and PD-L1. Cell death & disease 15 (8) (2024)
Ying Sui, Ziyang Shen, Xiaoyou Li, Ya Lu, SiTong Feng, Rong Ma, Jianzhong Wu, Changwen Jing, Zhuo Wang, Ji-Feng Feng, Haixia Cao
Rupatadine-inhibited OTUD3 promotes DLBCL progression and immune evasion through deubiquitinating MYL12A and PD-L1. Cell death & disease 15 (8) (2024)
Ying Sui, Ziyang Shen, Xiaoyou Li, Ya Lu, SiTong Feng, Rong Ma, Jianzhong Wu, Changwen Jing, Zhuo Wang, Ji-Feng Feng, Haixia Cao
Rupatadine-inhibited OTUD3 promotes DLBCL progression and immune evasion through deubiquitinating MYL12A and PD-L1. Cell death & disease 15 (8) (2024)